Related references
Note: Only part of the references are listed.Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4,5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity
Wagdy M. Eldehna et al.
SCIENTIFIC REPORTS (2022)
Optimization of the 4-anilinoquin(az)oline scaffold as epidermal growth factor receptor (EGFR) inhibitors for chordoma utilizing a toxicology profiling assay platform
Andrew A. Bieberich et al.
SCIENTIFIC REPORTS (2022)
Study of tyramine-binding mechanism and insecticidal activity of oil extracted from Eucalyptus against Sitophilus oryzae
Farshid Zargari et al.
FRONTIERS IN CHEMISTRY (2022)
Synthesis, Anti-Tomato Spotted Wilt Virus Activities, and Interaction Mechanisms of Novel Dithioacetal Derivatives Containing a 4(3H)-Quinazolinone Pyrimidine Ring
Guangcheng Zu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)
Uncertainty quantification in classical molecular dynamics
Shunzhou Wan et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2021)
8-Alkylmercaptocaffeine derivatives: antioxidant, molecular docking, and in-vitro cytotoxicity studies
Saman Sargazi et al.
BIOORGANIC CHEMISTRY (2021)
Quinazoline analogues as cytotoxic agents; QSAR, docking, and in silico studies
Leila Emami et al.
RESEARCH IN PHARMACEUTICAL SCIENCES (2021)
Synthesis, biological evaluation and molecular docking of pyrimidine and quinazoline derivatives of 1,5-benzodiazepine as potential anticancer agents
Apoorva Misra et al.
JOURNAL OF KING SAUD UNIVERSITY SCIENCE (2020)
A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy
Adileh Ayati et al.
BIOORGANIC CHEMISTRY (2020)
Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids
Prashant S. Auti et al.
RSC ADVANCES (2020)
Molecular Dynamics Simulation Framework to Probe the Binding Hypothesis of CYP3A4 Inhibitors
Yusra Sajid Kiani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial
Dong-Wan Kim et al.
LUNG CANCER (2019)
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships
Zhi Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Nano-SnCl4.SiO2, an efficient catalyst for synthesis of benzimidazole drivatives as antifungal and cytotoxic agents
Leila Zamani et al.
RESEARCH IN PHARMACEUTICAL SCIENCES (2019)
Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011-2016)
Abdul Hameed et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Synthesis of some quinazolinone derivatives using magnetic nanoparticles-supported tungstic acid as antimicrobial agents
Masoumeh Divar et al.
JOURNAL OF THE IRANIAN CHEMICAL SOCIETY (2018)
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D. Planchard et al.
ANNALS OF ONCOLOGY (2018)
Accuracy of Rotational Parameters Predicted by High-Level Quantum-Chemical Calculations: Case Study of Sulfur-Containing Molecules of Astrochemical Interest
Silvia Alessandrini et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2018)
Anti-cancer Nitrogen-Containing Heterocyclic Compounds
Zahra Hosseinzadeh et al.
CURRENT ORGANIC CHEMISTRY (2018)
Avoiding False Positive Conclusions in Molecular Simulation: The Importance of Replicas
Bernhard Knapp et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2018)
Rapid, Accurate, Precise, and Reliable Relative Free Energy Prediction Using Ensemble Based Thermodynamic Integration
Agastya P. Bhati et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2017)
Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues
Abdulrahman I. Almansour et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Pharmaceutical prospects of naturally occurring quinazolinone and its derivatives
Dan He et al.
FITOTERAPIA (2017)
Rapid and Reliable Binding Affinity Prediction of Bromodomain Inhibitors: A Computational Study
Shunzhou Wan et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2017)
A comparative QSAR analysis and molecular docking studies of phenyl piperidine derivatives as potent dual NK1R antagonists/serotonin transporter (SERT) inhibitors
Somayeh Zare et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2017)
On the calculation of equilibrium thermodynamic properties from molecular dynamics
Peter V. Coveney et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2016)
Recent advances in 4-aminoquinazoline based scaffold derivatives targeting EGFR kinases as anticancer agents
Rania S. M. Ismail et al.
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Rapid, Precise, and Reproducible Prediction of Peptide-MHC Binding Affinities from Molecular Dynamics That Correlate Well with Experiment
Shunzhou Wan et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor
Zofia Piotrowska et al.
CANCER DISCOVERY (2015)
Clustering Molecular Dynamics Trajectories for Optimizing Docking Experiments
Renata De Paris et al.
COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE (2015)
P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
Ziyad Binkhathlan et al.
CURRENT CANCER DRUG TARGETS (2013)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
Targeting the function of the HER2 oncogene in human cancer therapeutics
M. M. Moasser
ONCOGENE (2007)
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
Charles E. Geyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ruthenium complexes as anticancer agents
I Kostova
CURRENT MEDICINAL CHEMISTRY (2006)
The HER receptor family: A rich target for therapeutic development
RD Mass
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K
P Mark et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2001)
Studies leading to the identification of ZD1839 (Iressa™):: An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer
AJ Barker et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Share Paper
